Deerfield, Ill.-based devicemaker Baxter International said Dec. 2 it will acquire Sanofi’s Seprafilm Adhesion Barrier device and related assets for $350 million. Adhesion prevention products such as ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, has completed its previously announced acquisition of Seprafilm Adhesion Barrier and ...

To describe the long-term surgical outcomes of four patients treated for retinal detachment using Seprafilm as a novel technique. Retinal breaks in four eyes were covered with Seprafilm using a ...

Delivers on Baxter’s strategy to acquire products that are a strong fit with the company’s leading hemostat and sealant portfolio Plans to support the product through Baxter’s dedicated surgery ...

Sanofi has moved to offload its Seprafilm surgical barrier business, setting up a large infusion of cash for early next year as its new CEO prepares to unveil his new strategic priorities for the ...

(RTTNews) - Medical products company Baxter International Inc. (BAX) agreed Monday to acquire Seprafilm Adhesion Barrier and related assets from French drug maker Sanofi (SNYNF, SNY) to expand its ...

(Reuters) - Genzyme Corp agreed to pay $32.59 million, admit wrongdoing and enter a deferred prosecution agreement to resolve U.S. criminal charges over its marketing of the surgical implant Seprafilm ...

BLUES ASSOCIATION TAPS HIGHMARK CEO AS BOARD CHAIR: David L. Holmberg, president and chief executive officer of Pittsburgh-based Highmark Health, has been elected chairman of the Chicago-based Blue ...

Sanofi is in advanced talks to sell its Seprafilm surgical products unit to U.S. medical supply company Baxter International Inc., according to people with knowledge of the matter. Seprafilm could be ...

Genzyme Corp. agreed to pay $32.6 million to settle a US criminal probe into the biotechnology firm’s false marketing of Seprafilm, a gel developed to reduce internal scarring after abdominal and ...

Acquired product line is strong complement to the company’s leading Advanced Surgery portfolio Global integration process begins immediately to manage successful transition with customers and ...